HPV driven cancers, including HPV+ HNSCC, are characterized by defects in the DDR pathway, making them potentially susceptible to WEE1 inhibition. HPV+ cancers are those where the underlying cause is ...

Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, ...

A patient with HPV-positive head and neck squamous cell carcinoma was dosed in a phase 1 clinical trial evaluating APR-1051.

In March 2025, Coordination Pharmaceuticals Inc. announced a phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or ...

Phase 2 trial results support further development of neoadjuvant nivolumab-based CIT and adaptive de-escalation of CRT in patients with locoregionally advanced HNSCC, according to researchers.

A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and ...

Aprea Therapeutics (APRE) announced that a patient with HPV+ head and neck squamous cell carcinoma, HNSCC, has been dosed in the ongoing ...

Certain organs Digestive tract Respiratory tract When squamous cell carcinoma develops in the skin, you often find it on areas that are exposed to the sun, such as the: Face Ears Neck Lips Backs ...

After the news that Hollywood legend Val Kilmer has died, one man has opened up about his battle with a similar diagnosis of ...

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC). The research identified enolase 2 (ENO2), a ...

today announced that a patient with HPV+ head and neck squamous cell carcinoma (HNSCC) has been dosed in the ongoing ACESOT-1051 clinical trial evaluating APR-1051. This is the first patient to be ...